The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Open accessAbstract
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose ((18)F-FDG) and amino acid tracers ((11)C-MET, (18)F-FET, and (18)F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Self-citationOstrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Self-citationBevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Weller, M., van den Bent, M., Hopkins, K., Tonn, J. C., Stupp, R., Falini, A., Cohen-Jonathan-Moyal, E., Frappaz, D., Henriksson, R., Balana, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70011-7 · Cited by 750
Self-citationKumar, A. J., Leeds, N. E., Fuller, G. N., Van Tassel, P., Maor, M. H., Sawaya, R. E., & Levin, V. A. (2000) · Radiology · doi:10.1148/radiology.217.2.r00nv36377 · Cited by 669
Pauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen, W., Cloughesy, T. F., Kamdar, N. V., Satyamurthy, N., Bergsneider, M., Liau, L. M., Mischel, P. S., Czernin, J., Phelps, M. E., & Silverman, D. H. S. (2005) · PubMed · Cited by 437
Chen, W., Silverman, D. H. S., Delaloye, S., Czernin, J. G., Kamdar, N. V., Pope, W. B., Satyamurthy, N., Schiepers, C. W., & Cloughesy, T. F. (2006) · PubMed · Cited by 407
Self-citationPrediction of survival in glioma patients by means of positron emission tomography
Patronas, N. J., Chiro, G. D., Kufta, C., Bairamian, D., Kornblith, P. L., Simon, R., & Larson, S. M. (1985) · Journal of Neurosurgery · doi:10.3171/jns.1985.62.6.0816 · Cited by 405
Pseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
Grosu, A. L., Weber, W. A., Franz, M., Stärk, S., Piert, M., Thamm, R., Gumprecht, H., Schwaiger, M., Molls, M., & Nieder, C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.056 · Cited by 373
Magnetic resonance imaging and histopathology of cerebral gliomas
Watanabe, M., Tanaka, R., & Takeda, N. (1992) · Neuroradiology · doi:10.1007/bf00598951 · Cited by 329
Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma
P�pperl, G., G�tz, C., Rachinger, W., Gildehaus, F., Tonn, J. C., & Tatsch, K. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1590-1 · Cited by 293
Self-citationDelineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Klein, J. C., Herholz, K., & Heiss, W.-D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0262 · Cited by 292
Pöpperl, G., Kreth, F. W., Mehrkens, J. H., Herms, J., Seelos, K., Koch, W., Gildehaus, F. J., Kretzschmar, H. A., Tonn, J. C., & Tatsch, K. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0534-y · Cited by 288
Self-citationValue of 11C-methionine PET in imaging brain tumours and metastases
Glaudemans, A. W. J. M., Enting, R. H., Heesters, M. A. A. M., Dierckx, R. A. J. O., van Rheenen, R. W. J., Walenkamp, A. M. E., & Slart, R. H. J. A. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2295-5 · Cited by 286
Molecular imaging of gliomas with PET: Opportunities and limitations
la Fougere, C., Suchorska, B., Bartenstein, P., Kreth, F.-W., & Tonn, J.-C. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor054 · Cited by 274
Self-citationBrain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Sabel, M., Reifenberger, G., Kebir, S., Dorn, F., Blau, T., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2959-4 · Cited by 266
Self-citationComparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte, B. J. M., Goldman, S., Massager, N., David, P., Wikler, D., Vandesteene, A., Salmon, I. J., Brotchi, J., & Levivier, M. (2004) · PubMed · Cited by 248
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
Kunz, M., Thon, N., Eigenbrod, S., Hartmann, C., Egensperger, R., Herms, J., Geisler, J., la Fougere, C., Lutz, J., Linn, J., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq196 · Cited by 246
Self-citationDunet, V., Rossier, C., Buck, A., Stupp, R., & Prior, J. O. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.096859 · Cited by 244
Grosu, A., Weber, W., Riedel, E., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.045 · Cited by 242
Hutterer, M., Nowosielski, M., Putzer, D., Jansen, N. L., Seiz, M., Schocke, M., McCoy, M., Göbel, G., la Fougère, C., Virgolini, I. J., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos300 · Cited by 239
Self-citationPitfalls in the diagnosis of brain tumours
Omuro, A. M., Leite, C. C., Mokhtari, K., & Delattre, J.-Y. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70597-x · Cited by 222
Pafundi, D. H., Laack, N. N., Youland, R. S., Parney, I. F., Lowe, V. J., Giannini, C., Kemp, B. J., Grams, M. P., Morris, J. M., Hoover, J. M., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not002 · Cited by 218
Van Laere, K., Ceyssens, S., Van Calenbergh, F., de Groot, T., Menten, J., Flamen, P., Bormans, G., & Mortelmans, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1564-3 · Cited by 212
Galldiks, N., Langen, K.-J., Holy, R., Pinkawa, M., Stoffels, G., Nolte, K. W., Kaiser, H. J., Filss, C. P., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098590 · Cited by 204
Self-citationDiagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Rapp, M., Heinzel, A., Galldiks, N., Stoffels, G., Felsberg, J., Ewelt, C., Sabel, M., Steiger, H. J., Reifenberger, G., Beez, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109603 · Cited by 193
Self-citationPrognostic Value of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and MRI in Low-Grade Glioma
Floeth, F. W., Pauleit, D., Sabel, M., Stoffels, G., Reifenberger, G., Riemenschneider, M. J., Jansen, P., Coenen, H. H., Steiger, H.-J., & Langen, K.-J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037895 · Cited by 186
Dunet, V., Pomoni, A., Hottinger, A., Nicod-Lalonde, M., & Prior, J. O. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov148 · Cited by 183
Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM
Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., Simon, M., Pöpperl, G., Kreth, F. W., la Fougere, C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001262 · Cited by 172
Self-citationGalldiks, N., Rapp, M., Stoffels, G., Fink, G. R., Shah, N. J., Coenen, H. H., Sabel, M., & Langen, K.-J. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2251-4 · Cited by 171
Self-citationHutterer, M., Nowosielski, M., Putzer, D., Waitz, D., Tinkhauser, G., Kostron, H., Muigg, A., Virgolini, I. J., Staffen, W., Trinka, E., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086645 · Cited by 168
Ewelt, C., Floeth, F. W., Felsberg, J., Steiger, H. J., Sabel, M., Langen, K.-J., Stoffels, G., & Stummer, W. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.03.008 · Cited by 166
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
Nihashi, T., Dahabreh, I. J., & Terasawa, T. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3324 · Cited by 165
Pirotte, B. J. M., Levivier, M., Goldman, S., Massager, N., Wikler, D., Dewitte, O., Bruneau, M., Rorive, S., David, P., & Brotchi, J. (2009) · Neurosurgery · doi:10.1227/01.neu.0000338949.94496.85 · Cited by 161
Fueger, B. J., Czernin, J., Cloughesy, T., Silverman, D. H., Geist, C. L., Walter, M. A., Schiepers, C., Nghiemphu, P., Lai, A., Phelps, M. E., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.078592 · Cited by 159
Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
Jansen, N. L., Suchorska, B., Wenter, V., Schmid‐Tannwald, C., Todica, A. S., Eigenbrod, S., Niyazi, M., Tonn, J., Bartenstein, P., Kreth, F.-W., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144675 · Cited by 153
Self-citationGoldman, S., Levivier, M., Pirotte, B. J. M., Brucher, J., Wikler, D., Damhaut, P., Dethy, S., Brotchi, J., & Hildebrand, J. G. (1997) · PubMed · Cited by 153
Lee, I. H., Piert, M., Gomez‐Hassan, D. M., Junck, L., Rogers, L. R., Hayman, J. A., Haken, R. K. T., Lawrence, T. S., Cao, Y., & Tsien, C. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.050 · Cited by 150
Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
Jansen, N. L., Suchorska, B., Wenter, V., Eigenbrod, S., Schmid‐Tannwald, C., Zwergal, A., Niyazi, M., Drexler, M., Bartenstein, P., Schnell, O., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122333 · Cited by 141
Self-citationvon Schwarzenberg, J., Czernin, J. G., Cloughesy, T. F., Ellingson, B. M., Pope, W. B., Grogan, T., Elashoff, D. A., Geist, C. L., Silverman, D. H. S., Phelps, M. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1440 · Cited by 141
Self-citationPirotte, B. J. M., Goldman, S., Dewitte, O., Massager, N., Wikler, D., Lefranc, F., Taib, N. O. B., Rorive, S., David, P., Brotchi, J., et al. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.104.2.238 · Cited by 140
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
Galldiks, N., Kracht, L., Burghaus, L., Thomas, A., Jacobs, A. H., Heiss, W., & Herholz, K. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0002-5 · Cited by 139
Self-citationTreatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin
Mahmood, A., Lu, D., Qu, C., Goussev, A. V., Zhang, Z. G., Lu, C., & Chopp, M. (2007) · Journal of neurosurgery · doi:10.3171/jns-07/08/0392 · Cited by 138
18F-FDG PET of Common Enhancing Malignant Brain Tumors
Kosaka, N., Tsuchida, T., Uematsu, H., Kimura, H., Okazawa, H., & Itoh, H. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2660 · Cited by 137
Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors
Kratochwil, C., Combs, S. E., Leotta, K., Afshar-Oromieh, A., Rieken, S., Debus, J., Haberkorn, U., & Giesel, F. L. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not199 · Cited by 133
Massager, N., David, P., Goldman, S., Pirotte, B. J. M., Wikler, D., Salmon, I. J., Nagy, N., Brotchi, J., & Levivier, M. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.6.0951 · Cited by 131
Galldiks, N., Stoffels, G., Ruge, M. I., Rapp, M., Sabel, M., Reifenberger, G., Erdem, Z., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123836 · Cited by 131
Self-citation18F-FDOPA Kinetics in Brain Tumors
Schiepers, C. W., Chen, W. C., Cloughesy, T. F., Dahlbom, M. L., & Huang, S. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.039321 · Cited by 129
Filß, C., Galldiks, N., Stoffels, G., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129007 · Cited by 123
Self-citationIntegrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas
Piroth, M. D., Pinkawa, M., Holý, R., Klotz, J., Schaar, S., Stoffels, G., Galldiks, N., Coenen, H. H., Kaiser, H. J., Langen, K., et al. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-011-0060-5 · Cited by 122
Self-citationTripathi, M., Sharma, R., D'Souza, M. M., Jaimini, A., Panwar, P., Varshney, R., Datta, A., Kumar, N., Garg, G., Singh, D., et al. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181becfe0 · Cited by 120
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
Radbruch, A., Fladt, J. C., Kickingereder, P., Wiestler, B., Nowosielski, M., Baumer, P., Schlemmer, H., Wick, A., Heiland, S., Wick, W., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou129 · Cited by 118
Herrmann, K. A., Czernin, J. G., Cloughesy, T. F., Lai, A., Pomykala, K. L., Benz, M., Buck, A. K., Phelps, M. E., & Chen, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not166 · Cited by 115
Omuro, A. M. P., Beal, K. P., Gutin, P. H., Karimi, S., Correa, D. D., Kaley, T. J., DeAngelis, L. M., Chan, T. A.-T., Gavrilovic, I. T., Nolan, C. P., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0822 · Cited by 112
Jansen, N. L., Schwartz, C., Graute, V., Eigenbrod, S., Lutz, J., Egensperger, R., Pöpperl, G., Kretzschmar, H. A., Cumming, P. D., Bartenstein, P., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos259 · Cited by 109
Self-citationStockhammer, F., Plotkin, M., Amthauer, H., van Landeghem, F. K. H., & Woiciechowsky, C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9551-3 · Cited by 107
Harris, R. J., Cloughesy, T. F., Pope, W. B., Nghiemphu, P. L., Lai, A., Zaw, T., Czernin, J., Phelps, M. E., Chen, W., & Ellingson, B. M. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos141 · Cited by 106
Self-citationTralins, K. S., Douglas, J. G., Stelzer, K. J., Mankoff, D. A., Silbergeld, D. L., Rostomily, R. C., Hummel, S. M., Scharnhorst, J., Krohn, K. A., Spence, A. M., et al. (2002) · PubMed · Cited by 99
Early metabolic responses in temozolomide treated low-grade glioma patients
Wyss, M. T., Höfer, S., Bruehlmeier, M., Hefti, M., Uhlmann, C., Bärtschi, E., Buettner, U. W., & Roelcke, U. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9896-2 · Cited by 98
Galldiks, N., Ullrich, R. T., Schroeter, M., Fink, G. R., & Kracht, L. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1219-5 · Cited by 96
Self-citationFDG-PET as a Prognostic Factor in High-grade Astrocytoma
Witte, O. D., Lefranc, F., Levivier, M., Salmon, I. J., Brotchi, J., & Goldman, S. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1026518002800 · Cited by 94
Methyl-l-11C-Methionine PET as a Diagnostic Marker for Malignant Progression in Patients with Glioma
Ullrich, R. T., Kracht, L., Brunn, A., Herholz, K., Frommolt, P., Miletić, H., Deckert, M., Heiss, W., & Jacobs, A. H. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065904 · Cited by 94
Glioma surgery using a multimodal navigation system with integrated metabolic images
Tanaka, Y., Nariai, T., Momose, T., et al. (2008) · Journal of neurosurgery · doi:10.3171/2008.4.17569 · Cited by 93
Piroth, M. D., Holý, R., Pinkawa, M., Stoffels, G., Kaiser, H. J., Galldiks, N., Herzog, H. R., Coenen, H. H., Eble, M. J., & Langen, K. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.03.006 · Cited by 92
Self-citationMoulin-Romsee, G., D’Hondt, E., de Groot, T., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0557-4 · Cited by 91
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan
Colavolpe, C., Chinot, O. L., Métellus, P., Mancini, J., Barrié, M., Bequet, C., Tabouret, É., MUNDLER, O., Figarella‐Branger, D., & Guedj, É. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos012 · Cited by 81
Arbizu, J., Tejada, S., Martí-Climent, J. M., Díez-Valle, R., Prieto, E., Quincoces, G., Díaz, C. V., Idoate, M. A., Zubieta, J. L., Peñuelas, I., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2049-9 · Cited by 79
Self-citationMiwa, K., Matsuo, M., Ogawa, S.-I., Shinoda, J., Yokoyama, K., Yamada, J., Yano, H., & Iwama, T. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-181 · Cited by 76
Thon, N., Kunz, M., Lemke, L., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29259 · Cited by 74
Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy
Rozental, J. M., Levine, R. L., Mehta, M. P., Kinsella, T. J., Levin, A. B., Allan, O., Mendoza, M., Hanson, J. M., Schrader, D., & Nickles, R. J. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90204-h · Cited by 65
Spence, A. M., Muzi, M., Graham, M. M., O’Sullivan, F., Link, J. M., Lewellen, T. K., Lewellen, B., Freeman, S. D., Mankoff, D. A., Eary, J. F., et al. (2002) · PubMed · Cited by 64
Prieto, E., Martí-Climent, J. M., Domínguez‐Prado, I., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.085324 · Cited by 64
18F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors
Misch, M., Guggemos, A., Driever, P. H., Koch, A., Grosse, F., Steffen, I. G., Plotkin, M., & Thomale, U. (2014) · Child s Nervous System · doi:10.1007/s00381-014-2552-y · Cited by 58
Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas
Colavolpe, C., Métellus, P., Mancini, J., Barrié, M., Bequet, C., Figarella‐Branger, D., MUNDLER, O., Chinot, O. L., & Guedj, É. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0771-6 · Cited by 53
Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis?
Caroline, I., & Rosenthal, M. A. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.10.003 · Cited by 53
Galldiks, N., Dunkl, V., Kracht, L., Vollmar, S., Jacobs, A. H., Fink, G. R., & Schroeter, M. (2012) · Molecular Imaging · doi:10.2310/7290.2012.00022 · Cited by 46
Self-citationGiammarile, F., Cinotti, L., Jouvet, A., Ramackers, J. M., Pierre, G. S., Thiesse, P., Jouanneau, E., Guyotat, J., Pélissou-Guyotat, I., Setiey, A., et al. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000033384.43417.82 · Cited by 45
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Villani, V., Carapella, C. M., Chiaravalloti, A., et al. (2015) · PubMed · Cited by 38
Cited by
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048
Self-citationWen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Self-citationWeller, M., van den Bent, M., Tonn, J. C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., Henriksson, R., Rhun, E. L., Balana, C., Chinot, O., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30194-8 · Cited by 1,088
Self-citationLe Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx221 · Cited by 637
Self-citationLe Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.016 · Cited by 592
Self-citation
Metadata
- Authors
- Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C., Pope, W., Law, I., Arbizu, J., Chamberlain, M. C., Vogelbaum, M., Ellingson, B. M., & Tonn, J. C.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-21
- Volume
- 18
- Issue
- 9
- Pages
- 1199-1208
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2337855347
- Cited by
- 744
- References
- 85
- FWCI
- 45.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.